Lorcaserin, a 5-HT2C agonist, decreases nicotine self-administration in female rats.

http://www.ncbi.nlm.nih.gov/pubmed/21636655

Possible label expansions:
1) obesity
2) diabetes II
3) smoking cessation
4) depression
5) other addictive behaviors

Check.